Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma ; volume:19 ; number:1 ; day:11 ; month:10 ; year:2024 ; pages:1-9 ; date:12.2024
Radiation oncology ; 19, Heft 1 (11.10.2024), 1-9, 12.2024
- Urheber
-
Gonzalez, Lorein
Rubens, Muni
Yarlagadda, Sreenija
Rabinowits, Guilherme
Kalman, Noah S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-024-02516-4
- URN
-
urn:nbn:de:101:1-2412302104126.749781847253
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gonzalez, Lorein
- Rubens, Muni
- Yarlagadda, Sreenija
- Rabinowits, Guilherme
- Kalman, Noah S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer
Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy
Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control
Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer
Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy
Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control
Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer
Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy
Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation